WK Information’s purpose is to support clients to make informed optimal decisions. Our reports cover a variety of fields, from niche market to general market. Our consistent growth and ability to deliver in-depth analyses and market insight has engaged genuine.
Global cristobalite will increase steadily over the next...
The Gold Nanoparticles is forecast to crazy increase...
The Flue Gas Desulfurization is forecast to steadily...
According to the WK-chem Research “Global Epoxy Reactive...
Global Hyaluronic Acid Based Dermal Fillers Market InsightFebruary 8, 2022 Comments
According to the WK-chem Research “Global Hyaluronic Acid Based Dermal Fillers Professional Survey Report 2022, Forecast to 2027”,Rising demand for youthful and flawless skin through non-invasive and outpatient cosmetic dermatology techniques is expected to drive the Hyaluronic Acid Based Dermal Fillers market.The compound annual growth rate (CAGR) for the 2022-2027 period is projected to be 7.4% base on WK-chem Research regression analysis model.
“The need for aesthetic therapies and anti-aging cosmetic has risen as the world’s population has aged. Hyaluronic acid products are recommended with the increased need for minimally invasive anti-aging therapies due to its characteristic moisturizing and viscoelastic capabilities as well as lower level of toxicity. The global hyaluronic acid based dermal fillers market is likely to be driven by rising demand for younger looking and perfect skin through outpatient and noninvasive aesthetic dermatology methods. In addition to that, the market is further expected to benefit from an increase in medical tourism for various aesthetic treatments.”said Jack Lee, Senior analyst,Chemical & Material Market Research Center in WK-chem Research.
The global hyaluronic acid based dermal fillers market growth is majorly driven by the rising demand for invasive injection of dermal fillers to remove wrinkles from the skin and look young. The growth of the market is also the result of an increasing number of dermatology clinics in various regions across the globe. Another factor that is influencing the growth of global hyaluronic acid based dermal fillers market is the rise in technology to produce inject the filler into the skin coupled with the increase in the disposable income of the consumers, they can now invest in procedures involving dermal fillers. This, as a result, is also helping the global hyaluronic acid based dermal fillers market to grow exceptionally in the future. Although, as a result of high-cost of dermal filling procedures may hamper the growth of global hyaluronic acid based dermal fillers market. However, the rise in awareness about the procedure and urge to look young in the people shall allow the global hyaluronic acid based dermal fillers market to have promising growth in the future.
In 2017, Allergan acquired LifeCell and ZELTIQ Aesthetics to improve its portfolio facial aesthetics.
In April 2018, Merz Aesthetics launched a new line of its lip filler called Belotero lips. The lips filler had hyaluronic acid as its key constituent.
Galderma launched next-generation dermal fillers in December 2016 namely, Restylane and Restylane Defyne. The brand collaborated its product for the smoothening and consistent texture of the skin. The products offered benefits of flexibility and distributed product integration.
This WK-chem Research market report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading Hyaluronic Acid Based Dermal Fillers companies that include Allergan; Galderma Laboratories L.P.; Merz Pharmaceuticals; Genzyme Corporation; Anika Therapeutics Inc.; LG Life Sciences, LTD (LG Chem); Bio plus Co. Ltd.; Sculpt Luxury Dermal Fillers Ltd; Bioxis Pharmaceutical; Sinclair Pharma; Laboratories Vivacy; Bohus Biotech AB
Segmentation of Hyaluronic Acid Based Dermal Fillers Market:
Based on the product type, the market is categorized into single-phase products and duplex products. The single-phase fillers segment is expected to witness lucrative growth owing to multiple applications in skin and facial aesthetic procedures, comparatively fewer side effects, and rapid technological advancements for developing new fillers.Single-phase products are most preferred by dermatologists and consumers for correction of soft tissue facial deformities as the uncross-linked HA boosts elastin and collagen production that gives a youthful and healthy-looking glow to the skin. During the manufacturing process, single-phase products do not undergo the sizing technique—a process to breakdown the gel. Hylacross technology is used in the manufacturing of single-phase dermal fillers such as Juvederm Ultra, which results in product longevity with desirable effects.Duplex hyaluronic acid products are manufactured with Cohesive Polydensified Matrix (CPM) technology. Duplex products are used for the correction of glabellar lines and nasolabial folds owing to their increased durability. According to a study conducted on Belotero hyaluronic acid dermal filler, products manufactured with CPM technology possess soft flowing qualities, which allow smooth injection and homogenous tissue integration.
Based on the application, the hyaluronic acid-based dermal fillers market is classified into wrinkle removal, lip augmentation, rhinoplasty, and others. The wrinkle removal segment held the largest market share in 2018. This can be attributed to the increasing trend of social networking websites, insistent peer pressure, and popularity of the procedure among women as well as men of all age groups. Moreover, hyaluronic acid-based dermal fillers are gaining popularity for the correction of face structure and shape.Hyaluronic acid fillers are also widely used for the correction of lip structure and shape or enhancement of lip volume. Launch of new and innovative products specially designed for lip augmentation is expected to boost the market. For instance, in October 2017, Galderma Laboratories received FDA approval for Restylane Silk as the first hyaluronic acid dermal filler for injection via cannula.
Hyaluronic Acid Based Dermal Fillers Market: Regional Analysis
In terms of geography, the global Hyaluronic Acid Based Dermal Fillers market has been segmented into: North America, Asia Pacific, Europe, South America, and the Middle East and Africa.North America held the largest market share owing to the easy availability of products across the U.S. and Canada and increasing demand from middle-aged as well as young consumers. Hyaluronic acid dermal filler procedures were ranked second among noninvasive injectable procedures in the U.S.The European market is driven by factors such as a rapidly aging population and increasing awareness among people about advanced aesthetic procedures. An increase in per capita income of countries such as Spain is another factor leading to an increase in the adoption of dermal fillers in the region. The Asia Pacific is anticipated to witness the fastest growth in the coming years owing to the high demand for cosmetic and aesthetic products from countries such as Japan, China, South Korea, Thailand, Australia, and India. This demand is expected to increase due to the growing influence of social media and increasing awareness regarding minimally invasive procedures for cosmetic and aesthetic medicinal treatments. Moreover, the availability of these products at a lower cost is likely to spur the regional market.In Latin American countries such as Brazil, Mexico, Colombia, Venezuela, and Argentina, treatments involving the use of hyaluronic acid-based injectables are the fourth most widely performed nonsurgical aesthetic procedures. Also, medical tourism for dermal fillers is driving the market in this region. The selling price of hyaluronic acid-based dermal fillers is approximately lower in Latin America, leading to an increase in the number of people traveling to this region for these procedures.
Largest share area：North America
Largest share country：the Unite States
Product Type：Single-Phase Products and Duplex Products
Application：Wrinkle Removal, Lip Augmentation, Rhinoplasty, and Others
Leading Company：Allergan; Galderma Laboratories L.P.; Merz Pharmaceuticals; Genzyme Corporation; Anika Therapeutics Inc